Organon, Others Want $421M Medicaid FCA Suit Tossed
The relators claim the drug companies engaged in a variety of illegal kickbacks to long-term care pharmacies that sold the antidepressant Remeron, and defrauded the government by violating the Anti-Kickback Statute, the FCA and Medicaid “best price” laws.
The drug companies said that any...
Already a subscriber? Click here to login